Ultime notizie per AN2 Therapeutics (NASDAQ:ANTX) Azioni

AN2 THERAPEUTICS INC

Anthem

AN2 Therapeutics

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.

AN2 Therapeutics Inc

News

General

ONCO

Onconetix Receives Additional Notice From Nasdaq

AGFY

Agrify Corp. Enters Purchase Agreement With Vcp Ip Holdings To Acquire All Of Equity Interests In Mc Brands & Core Growth; Purchase Price For Acquisition Is $5.075M

Ross Stores, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROST#NASDAQ">ROST</a>) released its first-quarter results after Thursday's closing bell. Here's a look at the key details <a href="https://www.benzinga.com/pressreleases/25/05/b45573982/ross-stores-reports-first-quarter-earnings">from the report.</a>
The Details: Ross Stores reported quarterly earnings of $1.47 per share, which beat the Street estimate of $1.44. Quarterly revenue came in at $4.99 billion, which beat the $4.97 billion consensus estimate.
Read Next: <a href="https://www.benzinga.com/news/legal/25/05/45568107/solar-energy-stocks-drop-as-house-approves-major-rollback-of-climate-incentives?utm_source=article">Solar Energy Stocks Drop As House Approves Major Rollback Of Climate Incentives</a>
&#8220;Despite the slower start to the spring selling season in February, our monthly sales performance improved sharply, month after month, for the balance of the quarter. For the first quarter, sales and earnings performed at the high end of our expectations while operating margin of 12.2% was flat year-over-year,&#8221; Jim Conroy, CEO of Ross Stores, commented. 
Outlook:&nbsp;&#8220;Given the varying nature of tariff announcements, we are only providing an outlook for the second quarter at this time and are withdrawing our previously provided annual sales and earnings guidance,&#8221; said Conroy. 
Ross Stores said it sees second-quarter GAAP EPS&nbsp;in a range of $1.40 to $1.55, versus the $1.65&nbsp;analyst estimate. 
&#8220;The volatility of trade policies and the corresponding impact on the economy, the consumer, and our profitability is highly unpredictable. During these uncertain times, we will focus on what we can control and manage the business conservatively,&#8221; said Conroy. 
ROST Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Ross Stores stock was down 10.96% at $135.57 in Thursday's extended trading. 
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/rumors/25/05/45555558/wolfspeed-stock-plunges-59-on-bankruptcy-fears-options-traders-cash-in?utm_source=article">Wolfspeed Stock Plunges 59% On Bankruptcy Fears: Options Traders Cash In</a></li>
</ul>
Photo: Shutterstock

Earnings

After-Hours Center

Movers

ROST

Ross Stores Stock Plunges After Pulling Fiscal 2026 Revenue, Earnings Guidance: Details

VECO

Veeco Instruments Files For Mixed Shelf; Size Not Disclosed

WIIM

BULL

Webull shares are trading lower after the company reported Q1 financial results.

SOBR

SOBB Safe shares are trading higher after the company reported a year-over-year increase in Q1 EPS and sales results

BLMZ

BloomZ shares are trading higher after the company announced a business alliance with M-NEXT holdings.

Red River Bancshares, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RRBI#NASDAQ">RRBI</a>) (the "Company") announced today that, on May 22, 2025, the Company entered into a stock repurchase agreement with a shareholder for the repurchase by the Company of 100,000 shares of its common stock in a privately-negotiated transaction for a purchase price of $5.1 million. The purchase price reflects a discount to the 10-, 20-, and 30-day volume weighted average price on May 20, 2025. Blake Chatelain, the Company's President and Chief Executive Officer, said, "We are pleased to complete this repurchase, which shows our continued commitment to increasing shareholder value."
The repurchase is supplemental to the Company's previously announced $5.0 million repurchase program in effect through December 31, 2025 (the "Repurchase Program"), and does not impact the amount of permitted repurchases thereunder. As of May 22, 2025, the Company had approximately $4.7 million of remaining capacity under the Repurchase Program.

Buybacks

RRBI

Red River Bancshares Announces Company Enters Into a Stock Repurchase Agreement Of 100K Shares Of Its Common Stock In A Privately-Negotiated Transaction For A Purchase Price Of $5.1M

Xerox shares are trading lower after the company announced it reduced its quarterly dividend from $0.125 per share to $0.025.

Xerox shares are trading lower after the company cut its quarterly dividend in anticipation of the closing of the Lexmark transaction.

GYRE

Gyre Therapeutics shares are trading lower after the company announced a proposal for a public offering.

STEP

StepStone Group shares are trading higher after the company reported better-than-expected Q4 financial results.

The Goodyear Tire &amp; Rubber Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GT#NASDAQ">GT</a>) ("Goodyear" or the "Company") today announced that it has signed a definitive agreement to sell the majority of its Goodyear Chemical business to Gemspring Capital Management, LLC. The transaction follows a previously announced strategic review of Goodyear's Chemical business in connection with the Goodyear Forward transformation plan.
Goodyear Chemical is a leading producer of synthetic rubber, offering a broad product portfolio in North America and serving the automotive aftermarket as well as the consumer and industrial end markets. Pursuant to the transaction terms, Gemspring will pay Goodyear cash proceeds at closing of approximately $650 million, subject to certain post-closing adjustments, for Goodyear Chemical facilities in Houston and Beaumont, Texas, and a related research office in Akron, Ohio. Additionally, the transaction provides for a long-term supply agreement.
The transaction is subject to regulatory approval, as well as other customary closing conditions and is expected to close by late 2025. Goodyear intends to use transaction proceeds to reduce leverage and fund initiatives in connection with the Goodyear Forward transformation plan.
Goodyear will retain its Chemical facilities in Niagara Falls, New York, and Bayport, Texas, and its rights to the products produced at such facilities.

Goodyear Tire & Rubber Agrees To Sell Majority Of Goodyear Chemical Business To Gemspring Capital Management For About $650M

CPRT

Copart shares are trading lower after the company reported a Q3 revenue miss.

Dividends

Xerox Holdings Reduces Quarterly Dividend From $0.125 To $0.025

Franklin Templeton today announced it will liquidate and dissolve Western Asset Short Duration Income ETF (WINC) and Western Asset Total Return ETF (WBND). The liquidation is anticipated to occur on or about August 29, 2025. The liquidation of both WINC and WBND were approved by the Fund's board of trustees on May 21, 2025.
After the close of business on August 1, 2025, the Funds will no longer accept creation orders. Trading in the Funds on NASDAQ will be halted prior to market open on August 23, 2025. Proceeds of the liquidation are currently scheduled to be sent to shareholders on or about August 29, 2025.
When the Funds are in the process of liquidating their portfolios, which is anticipated to commence prior to August 23, 2025, the Funds will hold cash and securities that may not be consistent with the Funds' investment objectives and strategies.
Shareholders may sell their shares of a Fund on NASDAQ until the market close on August 22, 2025 and may incur the usual and customary brokerage commissions associated with the sale of Fund shares. The Funds' shares will no longer trade on NASDAQ after market close on August 22, 2025, and the shares will be subsequently delisted.
At the time the liquidation of the Funds is complete, shares of the Funds will be individually redeemed. Shareholders who do not sell their shares of a Fund before market close on August 22, 2025 will receive cash equal to the amount of the net asset value of their shares, which will include any capital gains and dividends, on or about August 29, 2025.

WBND

WINC

Franklin Templeton To Liquidate And Dissolve Western Asset Short Duration Income ETF And Western Asset Total Return ETF

Autodesk, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSK#NASDAQ">ADSK</a>) released its first-quarter results after Thursday's closing bell. Here's a look at the details <a href="https://www.benzinga.com/pressreleases/25/05/n45573992/autodesk-inc-announces-fiscal-2026-first-quarter-results">from the report.&nbsp;</a>
The Details: Autodesk reported quarterly earnings of $2.29 per share, which beat the analyst consensus estimate of $2.15. Quarterly revenue of $1.63 billion beat the Street estimate of $1.61 billion and is up from revenue of $1.42 billion from the same period last year.
Read Next: <a href="https://www.benzinga.com/news/legal/25/05/45568107/solar-energy-stocks-drop-as-house-approves-major-rollback-of-climate-incentives?utm_source=article">Solar Energy Stocks Drop As House Approves Major Rollback Of Climate Incentives</a>
&#8220;Against an uncertain geopolitical, macroeconomic, and policy backdrop, our strong performance in the first quarter of fiscal &#8217;26 set us up well for the year,&#8221; said Andrew Anagnost, Autodesk CEO.
&#8220;We continue to make the right decisions to drive long-term shareholder value by focusing on our strategic priorities in cloud, platform, and AI; optimizing our sales and marketing to drive higher margins; and allocating more capital to share repurchases as our free cash flow grows,&#8221; Anagnost added. 
Outlook:&nbsp;Autodesk expects second-quarter adjusted EPS of between $2.44 and $2.48, versus the &nbsp;$2.34&nbsp;analyst estimate, and revenue in a range of $1.72 billion to $1.73 billion, versus the $1.7 billion&nbsp;estimate.
The company raised its fiscal 2026 adjusted EPS guidance from a range of $9.34 to $9.67&nbsp;to a new range of $9.50 to $9.73, versus the $9.52&nbsp;estimate. Autodesk raised its fiscal revenue guidance from between&nbsp;$6.89 billion and $6.96 billion&nbsp;to&nbsp;between $6.92 billion and $7 billion, versus the $6.93 billion estimate. 
ADSK Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Autodesk stock was up 3.18% at $304.39 in Thursday&#8217;s extended trading.
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/government/regulations/25/05/45506863/trumps-big-beautiful-bill-advances-heres-who-wins-and-loses?utm_source=articleShare">Trump&#8217;s &#8216;Big Beautiful Bill&#8217; Advances: Here&#8217;s Who Wins And Loses&nbsp;</a></li>
</ul>
Photo: Shutterstock

Tech

ADSK

Autodesk Stock Climbs After Better-Than-Expected Q1 Results, Raised FY26 Guidance

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.graniteconstruction.com%2F&amp;esheet=54258658&amp;newsitemid=20250522718523&amp;lan=en-US&amp;anchor=Granite&amp;index=1&amp;md5=954c2d8cd7d45d097ac5976fe4c96545">Granite </a>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GVA#NYSE">GVA</a>) has been awarded an approximately $26 million contract by the San Francisco International Airport (SFO) to upgrade Taxiway Z and a portion of Taxiway S at SFO in San Francisco, California. Project funding is to come from SFO and will be included in Granite's second-quarter CAP.
This project will rehabilitate the taxiways to ensure the continued safety and efficiency of aircraft operations. Taxiway Z serves as a primary corridor for aircraft movement between the terminals, airline maintenance, and cargo facilities.

Granite Bags About $26M Contract From San Francisco International Airport To Upgrade Taxiway Z And Portion Of Taxiway S At SFO In San Francisco, California

CGBS

Crown LNG Holdings Receives Nasdaq Non-Compliance Notice

Intuit Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>) reported financial results for the third quarter of fiscal 2025 after the market close on Thursday. Here&#8217;s a rundown <a href="https://www.benzinga.com/pressreleases/25/05/b45573956/intuit-reports-strong-third-quarter-results-and-raises-full-year-guidance">of the report</a>.
Q3 Earnings: Intuit reported third-quarter revenue of $7.75 billion, beating analyst <a href="http://benzinga.com/quote/INTU/earnings">estimates</a> of $7.56 billion, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. The QuickBooks and TurboTax parent company reported third-quarter adjusted earnings of $11.65 per share, beating analyst estimates of $10.91 per share.
Total revenue was up 15% year-over-year. Here&#8217;s a breakdown of revenue by segment:
<ul class="wp-block-list">
<li>Consumer Group revenue: $4 billion, up 11%</li>
</ul>
<ul class="wp-block-list">
<li>Global Business Solutions revenue: $2.8 billion, up 19%</li>
</ul>
<ul class="wp-block-list">
<li>Credit Karma revenue: $579 million, up 31%</li>
</ul>
<ul class="wp-block-list">
<li>ProTax Group revenue: $278 million, up 9%</li>
</ul>
<ul class="wp-block-list">
<li>Online Ecosystem revenue: up 20%</li>
</ul>
Intuit repurchased $754 million of its stock in the quarter and had $2.8 billion remaining on its buyback at quarter&#8217;s end. The company said its board approved a quarterly dividend of $1.04 per share, payable on July 18. 
Intuit ended the quarter with $6.2 billion in total cash and investments and $6.4 billion of debt.
&#8220;We have exceptional momentum with outstanding performance across our platform. We&#8217;re redefining what&#8217;s possible with AI by becoming a one-stop shop of AI-agents and AI-enabled human experts to fuel the success of consumers and small and mid-market businesses,&#8221;&nbsp;said&nbsp;Sasan Goodarzi, CEO of Intuit.
Guidance:&nbsp;Intuit expects fourth-quarter revenue of $3.72 billion to $3.76 billion versus estimates of $3.76 billion. The company sees third-quarter adjusted earnings in the range of $2.63 to $2.68 per share versus estimates of $2.59 per share.&nbsp;
Intuit also raised its full-year guidance. The company expects full-year 2025 revenue of $18.72 billion to $18.76 billion, up from prior guidance of $18.16 billion and $18.35 billion. The company anticipates full-year earnings of $20.07 to $20.12 per share, up from prior guidance of $19.16 to $19.36, Analysts are currently looking for full-year revenue of $18.35 billion and full-year adjusted earnings of $19.34 per share, per <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Intuit&#8217;s management team will further discuss the quarter on a call with investors and analysts at 4:30 p.m. ET. 
INTU Price Action: <a href="https://www.benzinga.com/quote/INTU" target="_blank" rel="noreferrer noopener">Intuit shares</a> were up 8.25% in after-hours, trading at $721 at the time of publication on Thursday, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/top-stories/25/05/45570965/stocks-rebound-as-treasury-yields-fall-bitcoin-tops-111000-whats-driving-markets-thursday">Stocks Rebound As Treasury Yields Fall, Bitcoin Tops $111,000: What&#8217;s Driving Markets Thursday?</a></li>
</ul>
Photo: Shutterstock.

Guidance

INTU

Intuit Q3 Earnings: Revenue Beat, EPS Beat, Raised FY Guidance, Company Seeing 'Exceptional' Momentum Across Platforms

Press Releases

AN2 Therapeutics Receives Continuation Grant to Discover Novel Boron Based Therapies for Tuberculosis (caused by Mycobacterium tuberculosis) and Malaria

AN2 Therapeutics Reports Third Quarter 2024 Financial Results, Provides Important EBO-301 Update and Highlights Progress Across Boron Chemistry Pipeline

AN2 Therapeutics to Participate at Upcoming Investor Conferences

AN2 Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

AN2 Provides Strategic Update for Phase 3 EBO-301 Trial in Treatment Refractory MAC Lung Disease

AN2 Therapeutics to Present at Leerink Partners Global Healthcare Conference

AN2 Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business and Scientific Highlights

AN2 Therapeutics to Participate in Citizens JMP Life Sciences Conference

AN2 Therapeutics Reports Data from the Phase 3 Portion of Previously Terminated EBO-301 Study and Outlines Future Milestones from Boron Chemistry Pipeline

Comments

AN2 Therapeutics

Notizie

Ultime notizie per AN2 Therapeutics (NASDAQ:ANTX) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO